首页> 外文期刊>Helvetica chimica acta >Inhibition of Cellobiohydrolases from Trichoderma reesei. Synthesis and Evaluation of Some Glucose-, Cellobiose-, and Cellotriose-Derived Hydroximolactams and Imidazoles
【24h】

Inhibition of Cellobiohydrolases from Trichoderma reesei. Synthesis and Evaluation of Some Glucose-, Cellobiose-, and Cellotriose-Derived Hydroximolactams and Imidazoles

机译:里氏木霉纤维二糖水解酶的抑制。某些葡萄糖,纤维二糖和纤维三糖衍生的羟基异内酰胺和咪唑的合成和评价

获取原文
获取原文并翻译 | 示例
           

摘要

The lactam 16,the hydroximolactams 8, 20, 23, and 27, and the imidazole 32 were prepared following known metods. They were tested together with the known tetrazole 35 and hydroximolactams 2 and 36 as inhibitors of the cellobiohydrolases Ce 17A and Ce16A from Trichoderma reesei. Ce17A is only wekly inhibited by these compounds. Comparing their inhibitory activity evidences the importance of occupying subsites +1 and +2. The results stronly suggest that the shape of none of the variants of the lactone-type inhibitor motif embodied by these inhibitors is complementary to the subsite-1,i.e., analogous to the transition state. Ce16A is rather strongly inhibited by the cellobiose analogues 20,23,and 32, and by the cellotriose analogue 27. Their relative inhibitory activities evidence that binding at subsite-2 depends upon the shape of the moiety occupying subsite-1. There is only a small difference between the inhibition by the hydroximolactams 20 and 23, which may be (partially) protonated by the catalytic acid of either anto-or syn-protonating glycosidases,and the imidazole 32, which can only be protonated by anti-protonating glycosidases. The results strongly suggest that shape requirements must be met by glycosidase inhibitors before they can be used to characterize the proton trajectory of glycosidases.
机译:内酰胺16,羟内酰胺8、20、23和27以及咪唑32是按照已知的方法制备的。将它们与作为里氏木霉的纤维二糖水解酶Ce 17A和Ce16A的抑制剂的已知四唑35和氢西内酰胺2和36一起测试。 Ce17A仅被这些化合物弱抑制。比较它们的抑制活性证明了占据亚位点+1和+2的重要性。结果仅表明这些抑制剂所体现的内酯型抑制剂基序的任何变体的形状都不与亚位点1互补,即类似于过渡态。 Ce16A受到纤维二糖类似物20、23和32以及纤维三糖类似物27的强烈抑制。它们的相对抑制活性表明,亚位点2的结合取决于占据亚位点1的部分的形状。羟基内酰胺20和23的抑制作用之间仅有很小的差异,后者可以(部分)被正或质子化糖苷酶的催化酸质子化,而咪唑32只能被抗-内质子化酶质子化。质子化的糖苷酶。结果强烈表明,糖苷酶抑制剂必须满足形状要求,然后才能用于表征糖苷酶的质子轨迹。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号